Company description
Glucagon-Like Peptide 2 (GLP-2), a biologically active peptide secreted by the L-type enteroendocrine cells of the intestinal epithelium, has already shown therapeutic efficacy in several animal models of chronic intestinal disease. In addition, GLP-2 has been reported to enhance morphological and functional indexes of recovery following acute intestinal injury indexed by exposure to either 5-fluorouracil or nonsteroidal anti-inflammatory drugs.
